Perspective · 30 Dec 2025
Conference abstractPublished 24 Oct 2016
Structural implications of protease mutations in antiretroviral treatment exposed patients infected with HIV-1 subtype C
University of KwaZulu-Natal, South Africa
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The development of drug resistance mutations (DRMs) within protease often results in therapy failure. Currently, limited studies have focused on the structural implications of DRMs in subtype C. The study aim was to assess structural changes within protease that may provide insight into mutational pathways in subtype C. All protease subtype C sequences were retrieved from public databases. After quality assurance, 1912 sequences remained. Resistance associated mutations were identified via the HIVdb algorithm. Phenotypic variation (PV) was calculated using the ConSurf server. Homology models were predicted using Modeller. High PV indicative of drug pressure corresponded to the sheets, 30s loop, core and active site regions of protease. Interestingly, 296 unique combinations of DRMs occurred; the most common was M46I+I54V+V82A (n=27). Combinations of three or more occurred frequently suggesting that these combinations were not random but might have structural implications. M46I+154V+V82A showed greater distances between the mutated residues in comparison to the wild-type (WT). M46I+I54V+V82A+L76V was also common (n=14). V32I, a darunavir mutation directly interacted with L76V and V82A, moving inhibitors away from I84 and towards I50. I54L, also a darunavir mutation, increased the distance of the hydrogen bonds between the mutant and I47 to twice (4.286Ã?Â?) that of the WT (I54+I47), modifying flap flexibility and active site dynamics. The interaction of L76V with darunavir mutations V32I, I54L and I84V may have implications when switching to darunavir after lopinavir failure. Understanding DRM pathways in protease can help to prevent therapy failure and promote drug design for next generation protease inhibitors.
Subjects
Biochemistry & BiotechnologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Proteomics & Bioinformatics.
Commentary · 30 Dec 2025
Machine Learning in Bioinformatics Transforming Biological Data into Predictive Insights
Perspective · 30 Dec 2025
Post-Translational Modifications as Dynamic Regulators of Proteome Complexity and Cellular Function
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Proteomics & Bioinformatics
- SubjectBiochemistry & Biotechnology
- BylineArticles whose byline prints “Veronna Marie”
- BylineArticles whose byline prints “T Ndung′u”
- BylineArticles whose byline prints “M Gordon”
